The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

The Oncology Institute, Inc.NASDAQ: TOI

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables dips below year-ago levels

Q1 FY2026 accounts payables of $4.61M fell 8.8% year over year, behind the +142.5% change in trailing-twelve-month accounts payables. Sequentially, it fell 40.2% from the prior quarter.

Context

  • Accounts payables amounted to 3.9% of revenue in FY2025, up 1.6 pp from a year earlier.
  • Accounts payables increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -8.8% toward the trailing-twelve-month pace of +142.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.61M-40.2% QoQ
Last fiscal yearDec 2025
$19.64M+113.1% YoY
LTMMar 2026
$19.19M+142.5% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-8.8%——
1 year+113.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
19.64M USD
Year-over-year change
+113.1%
4-year CAGR
+61.1%

Accounts Payables vs competitors

How TOI compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +142.5% is the 2nd highest of 8, against a peer median of -134.0%.
  • Accounts payables amounts to 3.5% of revenue for TOI, versus a peer median of 0.6%.
TOI Competitors
Accounts Payables for TOI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AUNAAuna S.A.LTM Mar 2026PEN 30.65M PEN——0.7%
TOIThe Oncology Institute, Inc.LTM Mar 2026$19.19M USD+142.5%—3.5%
KIDSOrthoPediatrics Corp.LTM Mar 2026$3.66M USD+165.0%—1.5%
CCRNCross Country Healthcare, Inc.LTM Mar 2026$3.45M USD-134.0%—0.3%
EOLSEvolus, Inc.LTM Mar 2026$2.23M USD-153.0%+118.5%0.7%
AUTLAutolus Therapeutics plcLTM Mar 2026$1.74M USD-181.3%+289.5%1.9%
SNDASonida Senior Living, Inc.LTM Mar 2026$1.65M USD-163.8%—0.4%
CBLLCeriBell, Inc.LTM Mar 2026$543K USD+86.6%+141.4%0.6%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$314K USD+104.0%—0.2%
AGLAgilon Health, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding TOI) —-134.0%+141.4%0.6%

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(10.93M)152K(83.07M)(53.01M)(60.61M)
Depreciation & Amortization3.34M4.41M5.87M6.29M6.94M
Deferred Income Tax(1.24M)(263K)(76K)0(32K)
Stock-Based Compensation24.54M27.68M17.81M11.15M4.55M
Change in Working Capital(14.49M)(20.54M)2.36M18.06M1.33M
Accounts Receivables(2.99M)(19.67M)(4.5M)(5.77M)(12.58M)
Inventory(1.84M)(1.73M)(4.39M)3.64M(6.84M)
Accounts Payables2.92M(6.19M)5.06M9.22M19.64M
Other Working Capital(12.58M)7.04M6.19M10.98M1.11M
Other Non-Cash Items(33.9M)(73.2M)20.79M2.12M23.23M
Operating Cash Flow(32.68M)(61.76M)(36.32M)(26.54M)(24.59M)
Capital Expenditures(3.05M)(5.53M)(4.57M)(3.79M)(3.2M)
Acquisitions (Net)(9.11M)(8.58M)(4.46M)00
Purchases of Investments0(117.51M)(9.6M)00
Sales of Investments0081.26M50M126K
Other Investing Activities(200K)0000
Investing Cash Flow(12.15M)(131.61M)62.64M46.21M(3.07M)
Debt Repayment(7.25M)109.94M(101K)(39K)(20.04M)
Common Stock Issued00075K32.63M
Common Stock Repurchased0(9M)(1.02M)00
Dividends Paid00000
Other Financing Activities141.26M(8.74M)(5.73M)(3.53M)(1.04M)
Financing Cash Flow154.01M92.21M(6.85M)(3.49M)11.56M
Effect of Forex Changes00000
Net Change in Cash109.18M(101.16M)19.48M16.18M(16.1M)
Free Cash Flow(35.73M)(67.29M)(40.88M)(30.33M)(27.79M)

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.